Oxadiazoles as privileged motifs for promising anticancer leads: recent advances and future prospects

Imtiaz Khan1, Aliya Ibrar, Naeem Abbas

  • 1Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan.

Archiv Der Pharmazie
|November 23, 2013
PubMed

Insights

Novel anticancer agents are needed due to rising cancer incidence and chemotherapy side effects. Oxadiazole scaffolds show promise for developing potent and safer cancer therapies with improved efficacy.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Drug Discovery

Background:

  • Rising global cancer incidence necessitates novel therapeutic strategies.
  • Current chemotherapy drugs often cause severe side effects, limiting their use.
  • Targeted therapies offer hope but require careful design of bioactive pharmacophores.

Purpose of the Study:

  • To review recent advances in the design of anticancer agents based on oxadiazole scaffolds.
  • To highlight current developments and future perspectives in oxadiazole-based drug discovery.
  • To emphasize the importance of designing potent and selective anticancer agents.

Main Methods:

  • Literature review of recent research on oxadiazole derivatives as anticancer agents.
  • Analysis of structure-activity relationships for oxadiazole-based compounds.
  • Discussion of the potential of oxadiazole motifs in developing safer cancer therapies.

Main Results:

  • Oxadiazole scaffolds exhibit a well-defined anticancer activity profile.
  • Numerous studies demonstrate the efficacy of oxadiazole derivatives against various cancer cell lines.
  • The design of oxadiazole-based agents allows for improved potency and selectivity.

Conclusions:

  • Oxadiazole motifs are promising scaffolds for the development of novel anticancer drugs.
  • Future research should focus on optimizing oxadiazole derivatives for enhanced efficacy and reduced toxicity.
  • Oxadiazole-based drug discovery holds significant potential for improving cancer treatment outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K